Bushu plans $100 mil­lion ex­pan­sion for phar­ma­ceu­ti­cal in­spec­tion fa­cil­i­ty; RUC­DR breaks away from Rut­gers Uni­ver­si­ty, re­launch­es as IBX

In an ef­fort to be­come an “Asia hub” for phar­ma­ceu­ti­cal in­spec­tion and dis­tri­b­u­tion, con­tract man­u­fac­tur­er Bushu Phar­ma­ceu­ti­cals is pour­ing $100 mil­lion in­to the

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.